MicroRNAs in liver disease

Gastroenterology

Volumn 142, Issue 7, 2012, Pages 1431-1443

  Wang, Xin Wei ^a   Heegaard, Niels H H ^b   Orum, Henrik ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b STATENS SERUM INSTITUT   (Denmark)

^c Santaris Pharma AS   (Denmark)

Author keywords

Chronic Liver Disease; Cirrhosis; Hepatocellular Carcinoma; Liver Fibrosis

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 122; MICRORNA 125B; MICRORNA 146A; MICRORNA 151; MICRORNA 155; MICRORNA 181; MICRORNA 199; MICRORNA 200; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 26A; MICRORNA 29; MICRORNA 29B; MICRORNA 325; MICRORNA 34A; MICRORNA 370; MICRORNA 494; MICRORNA 99B; MIRAVIRSEN; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; APOPTOSIS; CANCER THERAPY; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; HEPATITIS C; HUMAN; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER REGENERATION; MICRORNA REPLACEMENT THERAPY; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; STELLATE CELL; SUBSTITUTION THERAPY; UNSPECIFIED SIDE EFFECT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 84861619812     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.04.007     Document Type: Review

References (150)

1. R.C. Lee, R.L. Feinbaum, V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
2. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
3. M.W. Jones-Rhoades, D.P. Bartel, B. Bartel MicroRNAs and their regulatory roles in plants Annu Rev Plant Biol 57 2006 19 53
4. G.A. Calin, C.D. Dumitru, M. Shimizu Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
5. G.A. Calin, C. Sevignani, C.D. Dumitru Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci U S A 101 2004 2999 3004
6. L. Zhang, D. Hou, X. Chen Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA Cell Res 22 2012 107 126
7. J. Krol, I. Loedige, W. Filipowicz The widespread regulation of microRNA biogenesis, function and decay Nat Rev Genet 11 2010 597 610
8. A. Pauli, J.L. Rinn, A.F. Schier Non-coding RNAs as regulators of embryogenesis Nat Rev Genet 12 2011 136 149
9. M. Dews, A. Homayouni, D. Yu Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat Genet 38 2006 1060 1065
10. A. Lujambio, G.A. Calin, A. Villanueva A microRNA DNA methylation signature for human cancer metastasis Proc Natl Acad Sci U S A 105 2008 13556 13561
11. L. He, X. He, L.P. Lim A microRNA component of the p53 tumour suppressor network Nature 447 2007 1130 1134
12. J. Ji, X.W. Wang New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma Cancer Biol Ther 8 2009 1686 1693
13. B.M. Ryan, A.I. Robles, C.C. Harris Genetic variation in microRNA networks: the implications for cancer research Nat Rev Cancer 10 2010 389 402
14. M.H. Chang, C.J. Chen, M.S. Lai et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1997 1855 1859
15. J. Schlutter Therapeutics: new drugs hit the target Nature 474 2011 S5 S7
16. B.I. Carr, J.C. Flickinger, M.T. Lotze Hepatobiliary cancers: cancer of the liver V.T. DeVita Jr S. Hellman, S.A. Rosenberg, Cancer principles & practice of oncology 5th ed. 1997 Lippincott-Raven Philadelphia, PA 1087 1114
17. D.M. Parkin, F. Bray, J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
18. H.B. El-Serag Hepatocellular carcinoma New Engl J Med 365 2011 1118 1127
19. G. Stefani, F.J. Slack Small non-coding RNAs in animal development Nat Rev Mol Cell Biol 9 2008 219 230
20. K.S. Zaret Regulatory phases of early liver development: paradigms of organogenesis Nat Rev Genet 3 2002 499 512
21. J. Krutzfeldt, N. Rajewsky, R. Braich Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689
22. J. Ji, T. Yamashita, A. Budhu Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells Hepatology 50 2009 472 480
23. C.L. Jopling, M. Yi, A.M. Lancaster Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 2005 1577 1581
24. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
25. B. Gao, R. Bataller Alcoholic liver disease: pathogenesis and new therapeutic targets Gastroenterology 141 2011 1572 1585
26. D. Baltimore, M.P. Boldin, R.M. O'Connell MicroRNAs: new regulators of immune cell development and function Nat Immunol 9 2008 839 845
27. S. Bala, M. Marcos, K. Kodys Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease J Biol Chem 286 2011 1436 1444
28. S. Cermelli, A. Ruggieri, J.A. Marrero Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease PLoS One 6 2011 e23937
29. C. Roderburg, G.W. Urban, K. Bettermann Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 2011 209 218
30. Y. Sekiya, T. Ogawa, K. Yoshizato Suppression of hepatic stellate cell activation by microRNA-29b Biochem Biophys Res Commun 412 2011 74 79
31. Y. Murakami, H. Toyoda, M. Tanaka The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families PLoS One 6 2011 e16081
32. J. Shu, B.T. Kren, Z. Xia Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration Hepatology 54 2011 609 619
33. Y. Murakami, T. Yasuda, K. Saigo Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues Oncogene 25 2006 2537 2545
34. A. Budhu, H.L. Jia, M. Forgues Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
35. J. Jiang, Y. Gusev, I. Aderca Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival Clin Cancer Res 14 2008 419 427
36. Y. Ladeiro, G. Couchy, C. Balabaud MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Hepatology 47 2008 1955 1963
37. H. Varnholt, U. Drebber, F. Schulze MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma Hepatology 47 2008 1223 1232
38. J. Ding, S. Huang, S. Wu Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA Nat Cell Biol 12 2010 390 399
39. S. Cairo, Y. Wang, A. de Reynies Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer Proc Natl Acad Sci U S A 107 2010 20471 20476
40. S. Ma, K.H. Tang, Y.P. Chan miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1 Cell Stem Cell 7 2010 694 707
41. J. Hou, L. Lin, W. Zhou Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma Cancer Cell 19 2011 232 243
42. F. Meng, R. Henson, H. Wehbe-Janek MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
43. S. Volinia, G.A. Calin, C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
44. L. Gramantieri, M. Ferracin, F. Fornari Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 67 2007 6092 6099
45. C. Coulouarn, V.M. Factor, J.B. Andersen Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties Oncogene 28 2009 3526 3536
46. J. Ji, L. Zhao, A. Budhu Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma J Hepatol 52 2010 690 697
47. M. Hatziapostolou, C. Polytarchou, E. Aggelidou An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis Cell 147 2011 1233 1247
48. H.B. El-Serag, K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
49. J. Ji, J. Shi, A. Budhu MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
50. J. Kota, R.R. Chivukula, K.A. O'donnell Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 2009 1005 1017
51. A. Esquela-Kerscher, P. Trang, J.F. Wiggins The let-7 microRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 7 2008 759 764
52. F. Meng, R. Henson, M. Lang Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines Gastroenterology 130 2006 2113 2129
53. F.M. Selaru, A.V. Olaru, T. Kan MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 Hepatology 49 2009 1595 1601
54. F. Meng, H. Wehbe-Janek, R. Henson Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes Oncogene 27 2008 378 386
55. A.V. Olaru, G. Ghiaur, S. Yamanaka MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint Hepatology 54 2011 2089 2098
56. N.J. Hand, Z.R. Master, J. Le Lay Hepatic function is preserved in the absence of mature microRNAs Hepatology 49 2009 618 626
57. S. Takagi, M. Nakajima, K. Kida MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle J Biol Chem 285 2010 4415 4422
58. M. Lagos-Quintana, R. Rauhut, A. Yalcin Identification of tissue-specific microRNAs from mouse Curr Biol 12 2002 735 739
59. Z.Y. Li, Y. Xi, W.N. Zhu Positive regulation of hepatic miR-122 expression by HNF4alpha J Hepatol 55 2011 602 611
60. M. Kwiecinski, A. Noetel, N. Elfimova Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction PLoS One 6 2011 e24568
61. T. Ogawa, M. Enomoto, H. Fujii MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis Gut 2012 Jan 20 [Epub ahead of print]
62. S. Yeligar, H. Tsukamoto, V.K. Kalra Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199 J Immunol 183 2009 5232 5243
63. D. Hanahan, R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
64. S.R. Viswanathan, G.Q. Daley, R.I. Gregory Selective blockade of microRNA processing by Lin28 Science 320 2008 97 100
65. I. Heo, C. Joo, J. Cho Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA Mol Cell 32 2008 276 284
66. S.R. Viswanathan, J.T. Powers, W. Einhorn Lin28 promotes transformation and is associated with advanced human malignancies Nat Genet 41 2009 843 848
67. T. Yamashita, A. Budhu, M. Forgues Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma Cancer Res 67 2007 10831 10839
68. D. Maetzel, S. Denzel, B. Mack Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 2009 162 171
69. J. Ji, T. Yamashita, X.W. Wang Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma Cell Biosci 1 2011 4
70. N. Oishi, X.W. Wang Novel therapeutic strategies for targeting liver cancer stem cells Int J Biol Sci 7 2011 517 535
71. M.P. Gantier, C.E. McCoy, I. Rusinova Analysis of microRNA turnover in mammalian cells following Dicer1 ablation Nucleic Acids Res 39 2011 5692 5703
72. P.S. Mitchell, R.K. Parkin, E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
73. A. Liu, M.T. Tetzlaff, P. Vanbelle MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues Int J Clin Exp Pathol 2 2009 519 527
74. M. de Planell-Saguer, M.C. Rodicio Analytical aspects of microRNA in diagnostics: A review Anal Chim Acta 699 2011 134 152
75. K.A. Cissell, S.K. Deo Trends in microRNA detection Anal Bioanal Chem 394 2009 1109 1116
76. C.K. Raymond, B.S. Roberts, P. Garrett-Engele Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs RNA 11 2005 1737 1744
77. C. Chen, D.A. Ridzon, A.J. Broomer Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res 33 2005 e179
78. P. Mestdagh, T. Feys, N. Bernard High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA Nucleic Acids Res 36 2008 e143
79. J. Gui, Y. Tian, X. Wen Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies Clin Sci (Lond) 120 2011 183 193
80. J.S. Jang, V.A. Simon, R.M. Feddersen Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays BMC Genomics 12 2011 144
81. G.K. Geiss, R.E. Bumgarner, B. Birditt Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
82. N.H. Heegaard, A.J. Schetter, J.A. Welsh Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer Int J Cancer 130 2012 1378 1386
83. P.T. Law, N. Wong Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma J Gastroenterol Hepatol 26 2011 437 449
84. R. Duttagupta, R. Jiang, J. Gollub Impact of cellular miRNAs on circulating miRNA biomarker signatures PLoS One 6 2011 e20769
85. Y. Zhang, Y. Jia, R. Zheng Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases Clin Chem 56 2010 1830 1838
86. R.C. Miranda, A.Z. Pietrzykowski, Y. Tang MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34 2010 575 587
87. J.E. Eipper-Mains, D.D. Kiraly, D. Palakodeti microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs RNA 17 2011 1529 1543
88. L. Zheng, G.C. Lv, J. Sheng Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD J Gastroenterol Hepatol 25 2010 156 163
89. X. Jin, Y.F. Ye, S.H. Chen MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease Dig Liver Dis 41 2009 289 297
90. X. Jiang, E. Tsitsiou, S.E. Herrick MicroRNAs and the regulation of fibrosis FEBS J 277 2010 2015 2021
91. R.T. Marquez, S. Bandyopadhyay, E.B. Wendlandt Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans Lab Invest 90 2010 1727 1736
92. R.A. Ach, H. Wang, B. Curry Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods BMC Biotechnol 8 2008 69
93. C. Camarillo, M. Swerdel, R.P. Hart Comparison of microarray and quantitative real-time PCR methods for measuring MicroRNA levels in MSC cultures Methods Mol Biol 698 2011 419 429
94. J.S. McDonald, D. Milosevic, H.V. Reddi Analysis of circulating microRNA: preanalytical and analytical challenges Clin Chem 57 2011 833 840
95. H. Dweep, C. Sticht, P. Pandey miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes J Biomed Inform 44 2011 839 847
96. M. Beitzinger, G. Meister Experimental identification of microRNA targets by immunoprecipitation of Argonaute protein complexes Methods Mol Biol 732 2011 153 167
97. J. Vinther, M.M. Hedegaard, P.P. Gardner Identification of miRNA targets with stable isotope labeling by amino acids in cell culture Nucleic Acids Res 34 2006 e107
98. Y. Yang, R. Chaerkady, K. Kandasamy Identifying targets of miR-143 using a SILAC-based proteomic approach Mol Biosyst 6 2010 1873 1882
99. O.A. Ebner, M. Selbach Whole cell proteome regulation by microRNAs captured in a pulsed SILAC mass spectrometry approach Methods Mol Biol 725 2011 315 331
100. B. Seliger, S. Jasinski, S.P. Dressler Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? J Proteome Res 10 2011 191 199
101. B. Seliger, S.P. Dressler, E. Wang Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma Proteomics 9 2009 1567 1581
102. C.W. Tseng, C.C. Lin, C.N. Chen Integrative network analysis reveals active microRNAs and their functions in gastric cancer BMC Syst Biol 5 2011 99
103. J. Satoh, H. Tabunoki Comprehensive analysis of human microRNA target networks BioData Min 4 2011 17
104. M. Kaller, S.T. Liffers, S. Oeljeklaus Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and micro-array analysis Mol Cell Proteomics 10 2011 M111.010462
105. D.R. Boutz, P.J. Collins, U. Suresh Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122 J Biol Chem 286 2011 18066 18078
106. B.A. Le, E. Portales-Casamar, G. Vetter MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model BMC Bioinformatics 12 2011 67
107. S. Guil, M. Esteller DNA methylomes, histone codes and miRNAs: tying it all together Int J Biochem Cell Biol 41 2009 87 95
108. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
109. H. Schwarzenbach, D.S. Hoon, K. Pantel Cell-free nucleic acids as biomarkers in cancer patients Nat Rev Cancer 11 2011 426 437
110. J.A. Weber, D.H. Baxter, S. Zhang The microRNA spectrum in 12 body fluids Clin Chem 56 2010 1733 1741
111. A. Turchinovich, L. Weiz, A. Langheinz Characterization of extracellular circulating microRNA Nucleic Acids Res 39 2011 7223 7233
112. K.C. Vickers, B.T. Palmisano, B.M. Shoucri MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat Cell Biol 13 2011 423 433
113. J.D. Arroyo, J.R. Chevillet, E.M. Kroh Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc Natl Acad Sci U S A 108 2011 5003 5008
114. N. Kosaka, H. Iguchi, Y. Yoshioka Secretory mechanisms and intercellular transfer of microRNAs in living cells J Biol Chem 285 2010 17442 17452
115. H. Valadi, K. Ekstrom, A. Bossios Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
116. H.M. Heneghan, N. Miller, A.J. Lowery Circulating microRNAs as novel minimally invasive biomarkers for breast cancer Ann Surg 251 2010 499 505
117. E.M. Kroh, R.K. Parkin, P.S. Mitchell Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods 50 2010 298 301
118. J. Xu, C. Wu, X. Che Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis Mol Carcinog 50 2011 136 142
119. H.J. Peltier, G.J. Latham Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues RNA 14 2008 844 852
120. H.Q. Guo, G.L. Huang, C.C. Guo Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma Dis Markers 29 2010 251 258
121. S. Asaga, C. Kuo, T. Nguyen Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer Clin Chem 57 2011 84 91
122. R. Albulescu, M. Neagu, L. Albulescu Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers Expert Rev Mol Diagn 11 2011 101 120
123. W. Gao, L. Liu, X. Lu Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma Clin Lung Cancer 12 2011 14 17
124. N. Kosaka, H. Iguchi, T. Ochiya Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis Cancer Sci 101 2010 2087 2092
125. N.C. Panarelli, R.K. Yantiss MicroRNA expression in selected carcinomas of the gastrointestinal tract Patholog Res Int 2011 2011 124608
126. J. Li, Y. Wang, W. Yu Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance Biochem Biophys Res Commun 406 2011 70 73
127. K. Wang, S. Zhang, B. Marzolf Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc Natl Acad Sci U S A 106 2009 4402 4407
128. L.M. Li, Z.B. Hu, Z.X. Zhou Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma Cancer Res 70 2010 9798 9807
129. J. Zhou, L. Yu, X. Gao Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma J Clin Oncol 29 2011 4781 4788
130. C. Roderburg, T. Mollnow, B. Bongaerts Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis PLoS One 7 2012 e32999
131. H. Osada, T. Takahashi MicroRNAs in biological processes and carcinogenesis Carcinogenesis 28 2007 2 12
132. R.L. Montgomery, E. van Rooij Therapeutic advances in MicroRNA targeting J Cardiovasc Pharmacol 57 2011 1 7
133. A.G. Bader, D. Brown, M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030
134. J. Stenvang, M. Lindow, S. Kauppinen Targeting of microRNAs for therapeutics Biochem Soc Trans 36 2008 1197 1200
135. P. Trang, J.F. Wiggins, C.L. Daige Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice Mol Ther 19 2011 1116 1122
136. F. Takeshita, L. Patrawala, M. Osaki Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes Mol Ther 18 2010 181 187
137. H. Ledford Drug giants turn their backs on RNA interference Nature 468 2010 487
138. J. Krutzfeldt, S. Kuwajima, R. Braich Specificity, duplex degradation and subcellular localization of antagomirs Nucleic Acids Res 35 2007 2885 2892
139. J.K. Park, T. Kogure, G.J. Nuovo miR-221 silencing blocks hepatocellular carcinoma and promotes survival Cancer Res 71 2011 7608 7616
140. J. Elmen, M. Lindow, A. Silahtaroglu Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver Nucleic Acids Res 36 2008 1153 1162
141. J. Elmen, M. Lindow, S. Schutz LNA-mediated microRNA silencing in non-human primates Nature 452 2008 896 899
142. J. Worm, J. Stenvang, A. Petri Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF Nucleic Acids Res 37 2009 5784 5792
143. J. Kocerha, M.A. Faghihi, M.A. Lopez-Toledano MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction Proc Natl Acad Sci U S A 106 2009 3507 3512
144. K.J. Rayner, Y. Suarez, A. Davalos MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 2010 1570 1573
145. S.H. Najafi-Shoushtari, F. Kristo, Y. Li MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 2010 1566 1569
146. P. Mu, Y.C. Han, D. Betel Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas Genes Dev 23 2009 2806 2811
147. C. le Sage, R. Nagel, D.A. Egan Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation EMBO J 26 2007 3699 3708
148. S. Obad, C.O. dos Santos, A. Petri Silencing of microRNA families by seed-targeting tiny LNAs Nat Genet 43 2011 371 378
149. C. Esau, S. Davis, S.F. Murray miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 3 2006 87 98
150. H.L. Janssen, H.W. Reesink, S. Zeuzem A randomized, double-blind, placebo (Plb) controlled safety and anti-viral proof of concept study of Miravirsen (Mir), an oligonucleotide targeting miR-122, in treatment naïve patients with genotype 1 (Gt1) chronic HCV infection Hepatology 54 2011 1430A